To use net proceeds from this offering, together with current cash resources, to advance aspertec 325 mg to market-readiness * Pricing of registered direct offering of 2.65 million shares of common stock at an offering price per share of …
I am going to take a deep dive into Plexure Group Limited’s (NZSE:PLX) most recent ownership structure, not a frequent subject of discussion among individual investors. When it comes toRead More...
Integrated Device Technology, Inc. Commences Exchange Offer to Acquire PLX Technology, Inc. May 22, 2012 09:00 …
Under the terms of the agreement, which was approved by the Boards of Directors of both companies, a subsidiary of Avago will commence a tender offer for all of the outstanding shares of PLX common stock for $6.50 per share in cash. …
PLX-PAD treatment reduced Incidence of revascularization and ... commenced an …
HAIFA, Israel, June 14, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, is delighted to announce that it has been invited by the Tel Aviv …
Under the terms of the agreement, unanimously approved by the boards of directors of both companies, IDT will acquire …
Pluristem said it will start preparations to keep an emergency stock of PLX-R18 on hand for use in such events. Full approval of the drug will depend on the results of a Phase III clinical trial. Pluristem said on Monday it is in discussions …
Pluristem said it will start preparations to keep an emergency stock of PLX-R18 on hand for use in such events. Full approval of the drug will depend on the results of a Phase III clinical trial. Pluristem said on Monday it is in discussions …